Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

POLYSPORIN SINGLES - Health Canada Drug Approval Details

Approvals/Health Canada/POLYSPORIN SINGLES

Authorized

STANDARD

POLYSPORIN SINGLES

johnson & johnson inc🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 1a145babc7b6bbba
Company: johnson & johnson inc
Type: Standard

Approval Details

Approval Id: 1a145babc7b6bbba
Drug Approval Canada Name: POLYSPORIN SINGLES
Product Name: POLYSPORIN SINGLES
Status: Cancelled Post Market
Status Date: 2023-12-08
Original Market Date: 2019-10-28
Din: 02481618
Drug Class: Human
Dosage Form: Ointment
Route Of Administration: Topical
Schedule: OTC
Ahfs: 84:04.04
Atc Original: D06AX30 COMBINATIONS OF ANTIBIOTICS
Atc Name: d 06 ax 30
Aig Number: 0231324002
Company Name: johnson & johnson inc
Company Address: 88 Mcnabb Street, Markham, Ontario, Canada, L3R 5L2

Active Ingredients

BACITRACIN ZINC

500 UNIT / G

POLYMYXIN B SULFATE

10000 UNIT / G

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

1a145babc7b6bbba

Type

Standard

Back to Health Canada Approvals